| Organism | PLatform Type | Dataset | Description of experiment | Medline | Documentation file |
Human 642 | AFFY 479 | A0001 | Oligonucleotide array data for tumor and normal colon tissues | 10359783 | A0001_DOC |
| AFFY004 | Molecular Classification of Human Carcinomas | 11606367 | AFFY004_DOC |
| GSE1000 | Osteosarcoma TE85 cell tissue culture study | | GSE1000_DOC |
| GSE1004 | Molecular profiles (HG-U95A) of dystrophin-deficient and normal human muscle | 12415109 | GSE1004_DOC |
| GSE10072 | Gene expression signature of cigarette smoking and its role in lung adenocarcinoma development and survival | | GSE10072_DOC |
| GSE1007A | Molecular profiles(HG-U95B,C,D,E) of dystrophin-deficient and normal human skeletal muscle | 12698323 | GSE1007A_DOC |
| GSE1007B | Molecular profiles(HG-U95B,C,D,E) of dystrophin-deficient and normal human skeletal muscle | 12698323 | GSE1007B_DOC |
| GSE1007C | Molecular profiles(HG-U95B,C,D,E) of dystrophin-deficient and normal human skeletal muscle | 12698323 | GSE1007C_DOC |
| GSE1007D | Molecular profiles(HG-U95B,C,D,E) of dystrophin-deficient and normal human skeletal muscle | 12698323 | GSE1007D_DOC |
| GSE1009 | Diabetic nephropathy | 15042541 | GSE1009_DOC |
| GSE1010 | FCHL study | | GSE1010_DOC |
| GSE1017 | Acute Quadriplegic Myopathy | | GSE1017_DOC |
| GSE1036 | Hemin timecourse 0-72h | 15252187 | GSE1036_DOC |
| GSE1045 | Estradiol Treated Breast Cancer Cells Expressing Mutant Estrogen Receptors | 15023342 | GSE1045_DOC |
| GSE1056 | Hypoxia and Hypoxia mimics | 15942021 | GSE1056_DOC |
| GSE1059 | Myometrial cells expressing CREB, CREM alpha, CREM tau2alpha, ATF2 or the ATF2-small gene | 15691874 | GSE1059_DOC |
| GSE1081 | Effect of a 4 hour treatment of 100 nM endothelin-1 on human primary lung fibroblasts | 15044479 | GSE1081_DOC |
| GSE1122 | Emphysema Lung Tissue Gene Expression Profiling | 15284076 | GSE1122_DOC |
| GSE1124 | Comparison between uncomplicated and severe malaria and between both and health | | GSE1124_DOC |
| GSE1132A | IFN-Gamma keratinocytes | 15145801 | GSE1132A_DOC |
| GSE1132B | IFN-Gamma keratinocytes | 15145801 | GSE1132B_DOC |
| GSE1133A | tissue-specific pattern of mRNA expression | 15075390 | GSE1133A_DOC |
| GSE1140 | PMBCs and the effect of exercise | 15194674 | GSE1140_DOC |
| GSE1141 | Inflammatory bowel disease (HG-U133A) | | GSE1141_DOC |
| GSE1142 | Inflammatory bowel disease (HG-U133B) | | GSE1142_DOC |
| GSE1144 | aging of cultured human myotubes | | GSE1144_DOC |
| GSE1145A | changes in cardiac transcription profiles brought about by heart failure | | GSE1145A_DOC |
| GSE1145B | changes in cardiac transcription profiles brought about by heart failure | | GSE1145B_DOC |
| GSE1147 | Sex Specific Transciption in Human Hypothalamus | | GSE1147_DOC |
| GSE1152A | Inflammatory bowel disease | | GSE1152A_DOC |
| GSE1152B | Inflammatory bowel disease | | GSE1152B_DOC |
| GSE1153 | Estrogen-regulated gene expression in human osteosarcoma cells stably transfected with estrogen receptor alpha or beta | 15033914 | GSE1153_DOC |
| GSE1158 | Wilms tumor versus Stratagene Universal Reference | | GSE1158_DOC |
| GSE1159 | Expression profiles of acute myeloid leukemia patient samples | 15084694 | GSE1159_DOC |
| GSE121A | Type 2 diabetes and insulin resistance | 12436343 | GSE121A_DOC |
| GSE121B | Type 2 diabetes and insulin resistance | 12436343 | GSE121B_DOC |
| GSE121C | Type 2 diabetes and insulin resistance | 12436343 | GSE121C_DOC |
| GSE121D | Type 2 diabetes and insulin resistance | 12436343 | GSE121D_DOC |
| GSE121E | Type 2 diabetes and insulin resistance | 12436343 | GSE121E_DOC |
| GSE1264 | Sindbis survivors | | GSE1264_DOC |
| GSE1277 | HGPC, in monolayer, 0.5 vs. 20% serum | 15094393 | GSE1277_DOC |
| GSE1278 | HGPC, in monolayer, 0.5% serum | 15094393 | GSE1278_DOC |
| GSE1295A | STRRIDE Study | 15347626 | GSE1295A_DOC |
| GSE1295B | STRRIDE Study | 15347626 | GSE1295B_DOC |
| GSE1296 | Simple ambient preservation of human tissues for RNA expression array analysis | 15537428 | GSE1296_DOC |
| GSE1297 | Incipient Alzheimer's Disease: Microarray Correlation Analyses | 14769913 | GSE1297_DOC |
| GSE1299A | Breast Cancer Cell Line Experiment | 15161944 | GSE1299A_DOC |
| GSE1299B | Breast Cancer Cell Line Experiment | 15161944 | GSE1299B_DOC |
| GSE1299C | Breast Cancer Cell Line Experiment | 15161944 | GSE1299C_DOC |
| GSE1300 | Hereditary Spastic Paraparesis | | GSE1300_DOC |
| GSE1302A | primary trophoblast study | 15161964 | GSE1302A_DOC |
| GSE1302B | primary trophoblast study | 15161964 | GSE1302B_DOC |
| GSE1302C | primary trophoblast study | 15161964 | GSE1302C_DOC |
| GSE1302D | primary trophoblast study | 15161964 | GSE1302D_DOC |
| GSE1302E | primary trophoblast study | 15161964 | GSE1302E_DOC |
| GSE1309 | Gene expession profiles for monoclonal cell lines with high or low levels of store-operated Ca2+ entry. | 15623568 | GSE1309_DOC |
| GSE1317 | Ultraviolet induced gene expression in human basal cell culture | | GSE1317_DOC |
| GSE1318A | Myb specificity determinants | 15105423 | GSE1318A_DOC |
| GSE1318B | Myb specificity determinants | 15105423 | GSE1318B_DOC |
| GSE1323 | Isogenic primary tumor/metastasis comparison | 16531451 | GSE1323_DOC |
| GSE1343 | Burn/Trauma Study | 15548831 | GSE1343_DOC |
| GSE1347 | Pre-analytical changes of mRNA Gene Expression as the result from prolonged storage | 15238145 | GSE1347_DOC |
| GSE1364 | Long-Term Storage of Human Cells at Ambient Temperature | 16155929 | GSE1364_DOC |
| GSE1377 | Kaposi's sarcoma-associated herpes virus | 15220917 | GSE1377_DOC |
| GSE1397 | Trisomy 21 and TS13 | 16420667 | GSE1397_DOC |
| GSE1400 | MCF-7 Fractionated RNA | 15574777 | GSE1400_DOC |
| GSE1402 | Juvenile Rheumatoid Arthritis Profiles In PBMC and SFMC | 15150433 | GSE1402_DOC |
| GSE1403 | Cyclosporine A timecourse 0, 12, 48 hours | 16049326 | GSE1403_DOC |
| GSE1407 | HIV-based vector infected cells | 15314653 | GSE1407_DOC |
| GSE1410 | ASLV vector infected 293t-TVA cells | | GSE1410_DOC |
| GSE1417 | Untreated vs. Camptothecin Treated HeLa cells | 15026349 | GSE1417_DOC |
| GSE1418 | Imatinib effects on CD34+ cells | 15618956 | GSE1418_DOC |
| GSE1420 | Barrett's esophagus, Barrett's-associated adenocarcinomas and normal esophageal epithelium | 15833844 | GSE1420_DOC |
| GSE1427A | Expression profiles in Blast Bank samples with AML/RAEB | | GSE1427A_DOC |
| GSE1427B | Expression profiles in Blast Bank samples with AML/RAEB | | GSE1427B_DOC |
| GSE1428 | Skeletal muscle sarcopenia | 15687482 | GSE1428_DOC |
| GSE1431 | Human prostate cancer tissues analyses | | GSE1431_DOC |
| GSE1432 | Transcriptional Response of Human Microglial Cells to Interferon-gamma | 16163375 | GSE1432_DOC |
| GSE1455 | Two week Storage and Rehydration of HEK 293 Cells at Ambient Temperature | 16155929 | GSE1455_DOC |
| GSE1456A | Gene expression of breast cancer tissue in a large population-based cohort of Swedish patients | 16280042 | GSE1456A_DOC |
| GSE1456B | Gene expression of breast cancer tissue in a large population-based cohort of Swedish patients | 16280042 | GSE1456B_DOC |
| GSE1460A | Gene Expression Profile during human CD4+ T cell differentiation | 15210650 | GSE1460A_DOC |
| GSE1460B | Gene Expression Profile during human CD4+ T cell differentiation | 15210650 | GSE1460B_DOC |
| GSE1462 | Mitochondrial disorders | 15728662 | GSE1462_DOC |
| GSE1466A | Expression profiles of ATL patients | | GSE1466A_DOC |
| GSE1466B | Expression profiles of ATL patients | | GSE1466B_DOC |
| GSE1469 | A549 lung pneumocytes cell line infected with wildtype and deletion mutation PAK strain Pseudomonas aeruginosa | 16207250 | GSE1469_DOC |
| GSE1470 | Epithelial stem cells co-cultured with the dermal papilla | 15292489 | GSE1470_DOC |
| GSE1473 | Beta-catenin/GFP | | GSE1473_DOC |
| GSE1474 | Caco-2 and T84 cells stimulated with with flagellin, lymphotox beta or TNF alpha | | GSE1474_DOC |
| GSE1481 | LCCS vs control comparison | 16155903 | GSE1481_DOC |
| GSE1485 | Natural variation in human gene expression | 15269782 | GSE1485_DOC |
| GSE1493 | Hematopoietic stem cell subsets | 15790771 | GSE1493_DOC |
| GSE1518 | Human endothelium exposed to shear stress and pressure | 16155357 | GSE1518_DOC |
| GSE1541 | A549 parenchymal cell activation | 15454581 | GSE1541_DOC |
| GSE1542A | Expression profile of pancreatic ductal cells | 16053509 | GSE1542A_DOC |
| GSE1542B | Expression profile of pancreatic ductal cells | 16053509 | GSE1542B_DOC |
| GSE1551 | dermatomyositis | 15852401 | GSE1551_DOC |
| GSE1561 | EORTC 10994 clinical trial | 15897907 | GSE1561_DOC |
| GSE1562 | Adenovirus-mediated E2F-1 gene transfer in melanoma cell line | 15656974 | GSE1562_DOC |
| GSE1563 | Kidney Transplant Rejection and Tissue Injury by Gene Profiling of Biopsies and Peripheral Blood Lymphocytes | 15307835 | GSE1563_DOC |
| GSE1572 | Gene regulation and DNA damage in the aging human brain | 15190254 | GSE1572_DOC |
| GSE1577 | T-ALL and T-lymphoblastic lymphoma | 16358311 | GSE1577_DOC |
| GSE1595 | Human bladder smooth muscle cells - effect of stretch in vitro | 15467014 | GSE1595_DOC |
| GSE1614 | Caco-2 differentiation | 12644633 | GSE1614_DOC |
| GSE1615A | Theca cell gene expression | 15598877 | GSE1615A_DOC |
| GSE1615B | Theca cell gene expression | 15598877 | GSE1615B_DOC |
| GSE1629 | Carious versus healthy pulp gene expression | 15869869 | GSE1629_DOC |
| GSE1643 | Normal Variance of Gene Expression in the Human Lung | 16498083 | GSE1643_DOC |
| GSE1644 | Leukotriene D4-triggered Transcriptome | 15322539 | GSE1644_DOC |
| GSE1648 | Osmotic Loading of Human Intervertebral Disc Cells | | GSE1648_DOC |
| GSE1650 | COPD Study | 15374838 | GSE1650_DOC |
| GSE1657A | Adipocyte Differentiation | | GSE1657A_DOC |
| GSE1657B | Adipocyte Differentiation | | GSE1657B_DOC |
| GSE1676 | DNA damage response (NCS treatment) in several siRNA-manipulated cellular systems | 15892871 | GSE1676_DOC |
| GSE1682 | Global gene expression analysis of human glioma (Hs 683) cell lines exposed to candoxin | 16309724 | GSE1682_DOC |
| GSE1692 | T98G growth arrest | 15525513 | GSE1692_DOC |
| GSE1703 | Determination of mRNA transcripts in HeLa cells that are regulated by RENT1 | 15448691 | GSE1703_DOC |
| GSE1709 | STS107 T-cell activation at 1g vs. vg | 16210397 | GSE1709_DOC |
| GSE1719 | Macular Degeneration | | GSE1719_DOC |
| GSE1724 | TGFbeta lung fibroblasts | | GSE1724_DOC |
| GSE1725 | Toxicity from radiation therapy associated with abnormal transcriptional responses to DNA damage | 15096622 | GSE1725_DOC |
| GSE1729 | Gene expression profile of acute myeloid leukemia | 15674361 | GSE1729_DOC |
| GSE1739 | SARS | | GSE1739_DOC |
| GSE1740 | Tassiulas IFN Array v1.0 | 15467722 | GSE1740_DOC |
| GSE1743 | De novo kidney transplantation without use of calcineurin inhibitors preserves renal structure and function | | GSE1743_DOC |
| GSE1746 | CD14+ cell analysis | | GSE1746_DOC |
| GSE1751 | Human blood expression for Huntington's disease versus control | 16043692 | GSE1751_DOC |
| GSE1764A | Effect of Oxandrolone on Muscle in Duchenne Muscular Dystrophy | 16263771 | GSE1764A_DOC |
| GSE1764B | Effect of Oxandrolone on Muscle in Duchenne Muscular Dystrophy | 16263771 | GSE1764B_DOC |
| GSE1786 | Vastus lateralis biopsies from healthy trained and sedentary males | 16260967 | GSE1786_DOC |
| GSE1789 | heart gene expression in Down syndrome | | GSE1789_DOC |
| GSE1792 | Melanoma progression model: Differential Gene Expression | 15958521 | GSE1792_DOC |
| GSE1793 | Melanoma progression model:DAC-mediated gene expression | 15958521 | GSE1793_DOC |
| GSE1801 | Human hematopoietic stem cell engraftment in goat | 16682618 | GSE1801_DOC |
| GSE1802 | CBCD34-TGFbeta targets | 15477587 | GSE1802_DOC |
| GSE1805 | TGFbeta targets in M091 cell line | 15477587 | GSE1805_DOC |
| GSE1815 | The Influence of Interferon Gamma on Gene Expression in Normal Human Bronchial Epithelial Cells | 15985639 | GSE1815_DOC |
| GSE1822 | EWS-FLI1-transfection of HEK293 | 15548687 | GSE1822_DOC |
| GSE1823 | IL-2 transfection of A673-cells | 15170886 | GSE1823_DOC |
| GSE1824 | Neuroblastoma cell lines | 15548687 | GSE1824_DOC |
| GSE1825 | SRBCT | 15548687 | GSE1825_DOC |
| GSE1832 | Time and Exercise effects on Human Skeletal Muscle | 14519196 | GSE1832_DOC |
| GSE1845 | Melanoma cell lines | 15967107 | GSE1845_DOC |
| GSE1848A | lung and tonsillar mast cells | 15470070 | GSE1848A_DOC |
| GSE1848B | lung and tonsillar mast cells | 15470070 | GSE1848B_DOC |
| GSE1849A | Differential Gene Expression in Pulmonary Artery Endothelial Cells Exposed to Sickle Cell Plasma | 15741505 | GSE1849A_DOC |
| GSE1849B | Differential Gene Expression in Pulmonary Artery Endothelial Cells Exposed to Sickle Cell Plasma | 15741505 | GSE1849B_DOC |
| GSE1862 | The search for enzymes responsible for metabolism of nucleoside analogs | | GSE1862_DOC |
| GSE1869 | Ischemic and Nonischemic CM and NF Hearts | 15769906 | GSE1869_DOC |
| GSE1880 | Role of LANA in KSHV latent infection | 15525642 | GSE1880_DOC |
| GSE1907 | Sarcoidosis + Follow-up study | | GSE1907_DOC |
| GSE1910 | Microarray analysis of activated mixed glial (microglia) and monocyte-derived macrophage gene expression. | 15579277 | GSE1910_DOC |
| GSE1919 | Rheumatoid arthritis | | GSE1919_DOC |
| GSE1922 | Leukemia study / K562 cell line | | GSE1922_DOC |
| GSE1923 | Identification of PDGF-dependent patterns of gene expression in U87 glioblastoma cells | 15994924 | GSE1923_DOC |
| GSE1925 | IFN-gamma priming | 16148108 | GSE1925_DOC |
| GSE1926 | Carboplatin Sensitivity in Ovarian Carcinoma | 16227411 | GSE1926_DOC |
| GSE1933 | Mast Cell_time series | 16911805 | GSE1933_DOC |
| GSE1937 | Collagen-GAG Biocompatibility Tests | | GSE1937_DOC |
| GSE1955 | Gene expression changes induced by K-ras oncogene in the human pancreatic duct epithelial cell line (H6c7) | | GSE1955_DOC |
| GSE1977 | Portrait of transcriptional responses to ultraviolet and ionizing radiation in human cells | 15356296 | GSE1977_DOC |
| GSE1982 | PBMCs from CCI-779 Treated RCC subjects | | GSE1982_DOC |
| GSE1987 | Non Small Cell Lung Cancer | | GSE1987_DOC |
| GSE2004 | scien-affy-human-87089 | | GSE2004_DOC |
| GSE2006 | Comparative microarray between normal and essential thrombocythemia platelets | 16113833 | GSE2006_DOC |
| GSE2018 | Human Lung Transplant - BAL | | GSE2018_DOC |
| GSE2034 | Breast cancer relapse free survival | 15721472 | GSE2034_DOC |
| GSE2040 | Human endothelial progenitor cells (EPC) vs. human umbilical vein endothelial cells (HUVEC) vs. CD14+ monocytes | 15665831 | GSE2040_DOC |
| GSE2044A | Combining gene expression data from different generations of oligonucleotide arrays | 15504239 | GSE2044A_DOC |
| GSE2044B | Combining gene expression data from different generations of oligonucleotide arrays | 15504239 | GSE2044B_DOC |
| GSE2049 | AML1-ETO target genes | 15731354 | GSE2049_DOC |
| GSE2060B | Characterize CREB target genes in different tissue types | 15753290 | GSE2060B_DOC |
| GSE2060C | Characterize CREB target genes in different tissue types | 15753290 | GSE2060C_DOC |
| GSE2067 | HCV_Core_Study | 16876223 | GSE2067_DOC |
| GSE207 | HDMTX_MP-1 pair | 12704389 | GSE207_DOC |
| GSE2077 | Gene expression in Cryptosporidium parvum-infected human ileocecal adenocarcinoma cells (HCT-8) | 14711592 | GSE2077_DOC |
| GSE208 | HDMTX_MP-10 pair | 12704389 | GSE208_DOC |
| GSE209 | HDMTX_MP-2 pair | 12704389 | GSE209_DOC |
| GSE2099 | control-ethanol liver RNA | 15705656 | GSE2099_DOC |
| GSE210 | HDMTX_MP-3 pair | 12704389 | GSE210_DOC |
| GSE2109 | Expression Project for Oncology (expO) | | GSE2109_DOC |
| GSE211 | HDMTX_MP-4 pair | 12704389 | GSE211_DOC |
| GSE2110 | Marrow-derived Mesenchymal stem cells(2004/12/24) | 15923633 | GSE2110_DOC |
| GSE2111 | Metal and Gene Expression | 16330358 | GSE2111_DOC |
| GSE2113 | Plasma cell dyscrasias expression profiles associated with distinct IGH translocations in multiple myeloma | 15735737 | GSE2113_DOC |
| GSE2117 | CALM-AF10 T-ALL | 16107895 | GSE2117_DOC |
| GSE212 | HDMTX_MP-5 pair | 12704389 | GSE212_DOC |
| GSE2125 | isolated alveolar macrophages | 16166618 | GSE2125_DOC |
| GSE213 | HDMTX_MP-6 pair | 12704389 | GSE213_DOC |
| GSE2135 | Filaria induced monocyte dysfunction and its reversal following treatment | 16861626 | GSE2135_DOC |
| GSE2138A | Colon cancer profiling | 16247484 | GSE2138A_DOC |
| GSE2138B | Colon cancer profiling | 16247484 | GSE2138B_DOC |
| GSE214 | HDMTX_MP-7 pair | 12704389 | GSE214_DOC |
| GSE2144 | Gene induction by low pH in oesophageal cells | 16113055 | GSE2144_DOC |
| GSE2149 | Gene Expression Profile of Primary Effusion Lymphoma | | GSE2149_DOC |
| GSE215 | HDMTX_MP-8 pair | 12704389 | GSE215_DOC |
| GSE2152 | The effect of FH mutations on fibroid expression profile | 16319128 | GSE2152_DOC |
| GSE216 | HDMTX_MP-9 pair | 12704389 | GSE216_DOC |
| GSE2164 | Gender-specific gene expression in post-mortem human brain | 14583743 | GSE2164_DOC |
| GSE217 | HDMTX-1 pair | 12704389 | GSE217_DOC |
| GSE2171 | HIV-1 infection in human PBMCs in vivo | 15897992 | GSE2171_DOC |
| GSE2174 | D4-ME effects | | GSE2174_DOC |
| GSE2175 | Differential gene expression in pituitary adenomas by oligonucleotide array analysis | 15994756 | GSE2175_DOC |
| GSE218 | HDMTX-10 pair | 12704389 | GSE218_DOC |
| GSE2189 | A549 teatement with MGd | | GSE2189_DOC |
| GSE219 | HDMTX-11 pair | 12704389 | GSE219_DOC |
| GSE2191 | pediatric AML and normal bone marrow | 12738660 | GSE2191_DOC |
| GSE220 | HDMTX-12 pair | 12704389 | GSE220_DOC |
| GSE2208 | gene expression study of blood monocytes | 15965235 | GSE2208_DOC |
| GSE221 | HDMTX-13 pair | 12704389 | GSE221_DOC |
| GSE222 | HDMTX-14 pair | 12704389 | GSE222_DOC |
| GSE2222 | FoxM1 siRNA profiles | 15958562 | GSE2222_DOC |
| GSE2225 | Letrozole-, Anastrozole- and Tamoxifen-Responsive Genes in MCF-7aro Cells | 15831674 | GSE2225_DOC |
| GSE223 | HDMTX-15 pair | 12704389 | GSE223_DOC |
| GSE2230 | Effects of hTERT overexpression on gene expression profiles in CD4+ T lymphocytes | 15741219 | GSE2230_DOC |
| GSE2232 | Caco-2 cells cocultured with E.coli Nissle 1917 | 16351713 | GSE2232_DOC |
| GSE2238 | Targets of cytostatic drugs in HT1080 fibrosarcoma | 16001973 | GSE2238_DOC |
| GSE224 | HDMTX-16 pair | 12704389 | GSE224_DOC |
| GSE2240A | Comparison of atrial tissue of patients with atrial fibrillation and sinus rhythm with ventricular gene expression | 15877233 | GSE2240A_DOC |
| GSE2240B | Comparison of atrial tissue of patients with atrial fibrillation and sinus rhythm with ventricular gene expression | 15877233 | GSE2240B_DOC |
| GSE2241 | HOXA5 transcriptional targets | 15757903 | GSE2241_DOC |
| GSE2248 | Human Mesenchymal stem cell | 15971941 | GSE2248_DOC |
| GSE225 | HDMTX-17 pair | 12704389 | GSE225_DOC |
| GSE2251 | Anti-prolif. effect of E2 in breast cancer cells that re-exp. ERalpha is mediated by aberr. regulat. of cell cycle genes | 15821115 | GSE2251_DOC |
| GSE2256 | Lens Epithelial Cells and Lens Cortical Fiber Cells | 15851978 | GSE2256_DOC |
| GSE226 | HDMTX-18 pair | 12704389 | GSE226_DOC |
| GSE227 | HDMTX-19 pair | 12704389 | GSE227_DOC |
| GSE228 | HDMTX-2 pair | 12704389 | GSE228_DOC |
| GSE2280 | Prediction of lymphatic metastasis from primary squamous cell carcinoma of the oral cavity | 15558013 | GSE2280_DOC |
| GSE229 | HDMTX-20 pair | 12704389 | GSE229_DOC |
| GSE2292 | U2OS-ERa, U2OS-ERb, and U2OS-ERab cells treated with 4HT or E2 | 15802376 | GSE2292_DOC |
| GSE2294 | A Modular Analysis of Breast Cancer Reveals a Novel Low-Grade Molecular Signature in Estrogen Receptor-Positive Tumors | 16740749 | GSE2294_DOC |
| GSE2298 | hGSTA4-4 transfection in HLE B-3 experiment | 16005854 | GSE2298_DOC |
| GSE2299A | Egr-1 induced gene expression changes in HUVECs | 16818645 | GSE2299A_DOC |
| GSE2299B | Egr-1 induced gene expression changes in HUVECs | 16818645 | GSE2299B_DOC |
| GSE230 | HDMTX-21 pair | 12704389 | GSE230_DOC |
| GSE231 | HDMTX-22 pair | 12704389 | GSE231_DOC |
| GSE232 | HDMTX-3 pair | 12704389 | GSE232_DOC |
| GSE2322 | Expression changes induced by transmigration in human neutrophils | 16861384 | GSE2322_DOC |
| GSE2326A | Suqamous Cell Carcinoma of Head and Neck | | GSE2326A_DOC |
| GSE2326B | Suqamous Cell Carcinoma of Head and Neck | | GSE2326B_DOC |
| GSE2327 | siRNA mediated WTAP knockdown in HUVEC | | GSE2327_DOC |
| GSE2328A | Application of genome-wide expression analysis to human health & disease | 15781863 | GSE2328A_DOC |
| GSE2328B | Application of genome-wide expression analysis to human health & disease | 15781863 | GSE2328B_DOC |
| GSE233 | HDMTX-4 pair | 12704389 | GSE233_DOC |
| GSE234 | HDMTX-5 pair | 12704389 | GSE234_DOC |
| GSE235 | HDMTX-6 pair | 12704389 | GSE235_DOC |
| GSE2350 | Normal and transformed human mature B cells | 15778709 | GSE2350_DOC |
| GSE2351 | chemotherapy cross-resistance and treatment response in childhood acute lymphoblastic leukemia | | GSE2351_DOC |
| GSE236 | HDMTX-7 pair | 12704389 | GSE236_DOC |
| GSE237 | HDMTX-8 pair | 12704389 | GSE237_DOC |
| GSE238 | HDMTX-9 pair | 12704389 | GSE238_DOC |
| GSE239 | LDMTX_MP-1 pair | 12704389 | GSE239_DOC |
| GSE240 | LDMTX_MP-10 pair | 12704389 | GSE240_DOC |
| GSE241 | LDMTX_MP-11 pair | 12704389 | GSE241_DOC |
| GSE242 | LDMTX_MP-12 pair | 12704389 | GSE242_DOC |
| GSE2429 | Atypical Ductal Hyperplasia | 15864312 | GSE2429_DOC |
| GSE243 | LDMTX_MP-13 pair | 12704389 | GSE243_DOC |
| GSE244 | LDMTX_MP-14 pair | 12704389 | GSE244_DOC |
| GSE2443 | Prostate cancer - comparison of androgen-dependent and -independent microdissected primary tumor | 16203770 | GSE2443_DOC |
| GSE245 | LDMTX_MP-15 pair | 12704389 | GSE245_DOC |
| GSE246 | LDMTX_MP-16 pair | 12704389 | GSE246_DOC |
| GSE247 | LDMTX_MP-2 pair | 12704389 | GSE247_DOC |
| GSE248 | LDMTX_MP-3 pair | 12704389 | GSE248_DOC |
| GSE249 | LDMTX_MP-4 pair | 12704389 | GSE249_DOC |
| GSE250 | LDMTX_MP-5 pair | 12704389 | GSE250_DOC |
| GSE251 | LDMTX_MP-6 pair | 12704389 | GSE251_DOC |
| GSE252 | LDMTX_MP-7 pair | 12704389 | GSE252_DOC |
| GSE253 | LDMTX_MP-8 pair | 12704389 | GSE253_DOC |
| GSE254 | LDMTX_MP-9 pair | 12704389 | GSE254_DOC |
| GSE255 | MP-1 pair | 12704389 | GSE255_DOC |
| GSE2552 | Mapping Determinants of Human Gene Expression by Regional and Whole Genome Association | 16251966 | GSE2552_DOC |
| GSE256 | MP-10 pair | 12704389 | GSE256_DOC |
| GSE257 | MP-11 pair | 12704389 | GSE257_DOC |
| GSE258 | MP-12 pair | 12704389 | GSE258_DOC |
| GSE259 | MP-2 pair | 12704389 | GSE259_DOC |
| GSE260 | MP-3 pair | 12704389 | GSE260_DOC |
| GSE2603 | Subpopulations of MDA-MB-231 and Primary Breast Cancers | 16049480 | GSE2603_DOC |
| GSE261 | MP-4 pair | 12704389 | GSE261_DOC |
| GSE262 | MP-5 pair | 12704389 | GSE262_DOC |
| GSE263 | MP-6 pair | 12704389 | GSE263_DOC |
| GSE264 | MP-7 pair | 12704389 | GSE264_DOC |
| GSE265 | MP-8 pair | 12704389 | GSE265_DOC |
| GSE266 | MP-9 pair | 12704389 | GSE266_DOC |
| GSE267 | LDMTX_MP | 12704389 | GSE267_DOC |
| GSE268 | HDMTX | 12704389 | GSE268_DOC |
| GSE269 | HDMTX_MP | 12704389 | GSE269_DOC |
| GSE270 | MP | 12704389 | GSE270_DOC |
| GSE2724 | The effect of FH mutations on fibroid expression profile, normal myometrium vs. FH-mutant fibroids. | 16319128 | GSE2724_DOC |
| GSE281 | Inflammatory myopathy | 12391344 | GSE281_DOC |
| GSE2990 | Gene Expression Profiling in Breast Cancer: Understanding the Molecular Basis of Histologic Grade To Improve Prognosis | 16478745 | GSE2990_DOC |
| GSE3013 | Actions of tamoxifen in the uterus and its molecular effectors in endometrial carcinogenesis. | 16355216 | GSE3013_DOC |
| GSE3141 | Lung Cancer Dataset | 16273092 | GSE3141_DOC |
| GSE3143 | Breast Cancer Dataset | 16273092 | GSE3143_DOC |
| GSE3156 | Breast Cancer Cell Lines | 16273092 | GSE3156_DOC |
| GSE3185A | Human Glioblastoma | | GSE3185A_DOC |
| GSE3185B | Human Glioblastoma | | GSE3185B_DOC |
| GSE3188A | Hypoxic regulation of gene expression is dominated by the HIF system and can be mimicked by DMOG | 16565084 | GSE3188A_DOC |
| GSE3188B | Hypoxic regulation of gene expression is dominated by the HIF system and can be mimicked by DMOG | 16565084 | GSE3188B_DOC |
| GSE349 | Resistant | 12907009 | GSE349_DOC |
| GSE3494A | An expression signature for p53 in breast cancer predicts mutation status, transcriptional effects, and patient survival | 16141321 | GSE3494A_DOC |
| GSE3494B | An expression signature for p53 in breast cancer predicts mutation status, transcriptional effects, and patient survival | 16141321 | GSE3494B_DOC |
| GSE350 | Sensitive | 12907009 | GSE350_DOC |
| GSE3529 | Profiling of three different ER+ breast cancer cell lines grown in the presence and absence of estrogen. | 15986123 | GSE3529_DOC |
| GSE3542 | Profiling of MCF-7 cell lines stably overexpressing (ca)Raf-1, (ca)MEK, (ca)erbB-2, or ligand-activatable EGFR. | 16585219 | GSE3542_DOC |
| GSE3589 | Leukotriene D4- and Thrombin-Triggered Transcriptomes in Human Umbilical Vein Endothelial Cells | 16606835 | GSE3589_DOC |
| GSE360 | Macrophages and dendritic cells exposed to phylogenetically distinct parasites | 12663451 | GSE360_DOC |
| GSE3744 | Human breast tumor expression | 16473279 | GSE3744_DOC |
| GSE3834A | Profiling of ER+ BrC cells with and without estradiol in both cell cultures and xenografts | | GSE3834A_DOC |
| GSE3834B | Profiling of ER+ BrC cells with and without estradiol in both cell cultures and xenografts | | GSE3834B_DOC |
| GSE3893A | Gene Expression Profiling of matched Ductal Carcinomas in Situ and Invasive Breast Tumors | 16707453 | GSE3893A_DOC |
| GSE3893B | Gene Expression Profiling of matched Ductal Carcinomas in Situ and Invasive Breast Tumors | 16707453 | GSE3893B_DOC |
| GSE3894 | Heterozygous carriers of Nijmegen Breakage Syndrome Have a Distinct Gene Expression Phenotype. | 16809669 | GSE3894_DOC |
| GSE4006 | Estrogen effects on MCF-7 breast cancer cells co-expressing ERa and ERb | 16809442 | GSE4006_DOC |
| GSE4025 | Gene Expression Preferentially Regulated by Tamoxifen in Breast Cancer Cells | 16849584 | GSE4025_DOC |
| GSE412 | Treatment-specific changes in gene expression discriminate in vivo drug response in human leukemia cells | 12704389 | GSE412_DOC |
| GSE420 | Aortic stiffness | 14530203 | GSE420_DOC |
| GSE427 | Human Fibroblast Set: Hacia Laboratory | 12840040 | GSE427_DOC |
| GSE4292 | PTHrP-responsive genes in breast cancer | 16551631 | GSE4292_DOC |
| GSE430 | Effect of left ventricular assist device support on congestive heart failure patients | 12824457 | GSE430_DOC |
| GSE443 | Leprosy lesion gene expression | 12970564 | GSE443_DOC |
| GSE448 | WS1 response to high dose of UV-C | 12907719 | GSE448_DOC |
| GSE449 | WS1 response to low dose of UV-C | 12907719 | GSE449_DOC |
| GSE4573 | Gene expression signatures for predicting prognosis of squamous cell lung carcinomas | 16885343 | GSE4573_DOC |
| GSE465A | Expression profiling in the muscular dystrophies | 11121445 | GSE465A_DOC |
| GSE465B | Expression profiling in the muscular dystrophies | 11121445 | GSE465B_DOC |
| GSE465C | Expression profiling in the muscular dystrophies | 11121445 | GSE465C_DOC |
| GSE465D | Expression profiling in the muscular dystrophies | 11121445 | GSE465D_DOC |
| GSE465E | Expression profiling in the muscular dystrophies | 11121445 | GSE465E_DOC |
| GSE4668 | Expression data from hormone-starved MCF7/BUS cell culture | 14610279 | GSE4668_DOC |
| GSE468 | Expression profiling of medulloblastoma | 11544480 | GSE468_DOC |
| GSE4922A | Genetic Reclassification of Histologic Grade Delineates New Clinical Subtypes of Breast Cancer | | GSE4922A_DOC |
| GSE4922B | Genetic Reclassification of Histologic Grade Delineates New Clinical Subtypes of Breast Cancer | | GSE4922B_DOC |
| GSE493A | Gene expression profiling in DQA1*0501+ children with untreated dermatomyositis | 11937576 | GSE493A_DOC |
| GSE500 | CD34+ cell analysis | 11669215 | GSE500_DOC |
| GSE5102 | Genomic profile of the estrogen induced neoplastic transformation of the human breast epithelial cell MCF10F | | GSE5102_DOC |
| GSE511 | Proliferating normal human peripheral blood mononuclear cells infected with HIV type 1 RF | 11839152 | GSE511_DOC |
| GSE516 | TNF treated Synoviocytes | 12965196 | GSE516_DOC |
| GSE5327 | Breast cancer relapse free survival and lung metastasis free survival | 17420468 | GSE5327_DOC |
| GSE567 | Essential Thrombocythemia (ET) vs Normal (baseline) Megakaryocytes | 15271793 | GSE567_DOC |
| GSE574 | Idiopathic thrombocytopenic purpura (ITP) | 12937414 | GSE574_DOC |
| GSE5859A | Allelic Differences Account for Gene Expression Differences Among Population. | 17206142 | GSE5859A_DOC |
| GSE590 | USF1 haplotype comparison | 14991056 | GSE590_DOC |
| GSE595 | Human skeletal muscle | 14625377 | GSE595_DOC |
| GSE609A | SCID vs Normal Thymocyte Comparisons | 14602880 | GSE609A_DOC |
| GSE609B | SCID vs Normal Thymocyte Comparisons | 14602880 | GSE609B_DOC |
| GSE620A | Gene expression profile analysis of 4-phenylbutyrate treatment of IB3-1 bronchial epithelial cell line | 14583596 | GSE620A_DOC |
| GSE620B | Gene expression profile analysis of 4-phenylbutyrate treatment of IB3-1 bronchial epithelial cell line | 14583596 | GSE620B_DOC |
| GSE6253A | A Gene Expression Signature Predicts Survival of Patients with Stage I Non-Small Cell Lung Cancer | 17194181 | GSE6253A_DOC |
| GSE6253B | A Gene Expression Signature Predicts Survival of Patients with Stage I Non-Small Cell Lung Cancer | 17194181 | GSE6253B_DOC |
| GSE6253C | A Gene Expression Signature Predicts Survival of Patients with Stage I Non-Small Cell Lung Cancer | 17194181 | GSE6253C_DOC |
| GSE635 | Identification of novel genomic determinants of cellular drug resistance in acute lymphoblastic leukemia. | 15295046 | GSE635_DOC |
| GSE6429 | HGPC, in monolayer, 0.5 vs. 20% serum, complete | | GSE6429_DOC |
| GSE643 | ASP sensitive all ALL | 15295046 | GSE643_DOC |
| GSE6434 | Docetaxel treatment of sensitve and resistant patients | | GSE6434_DOC |
| GSE645 | ASP resistant all ALL | 15295046 | GSE645_DOC |
| GSE646 | PRED sensitive all ALL | 15295046 | GSE646_DOC |
| GSE647 | PRED resistant all ALL | 15295046 | GSE647_DOC |
| GSE648 | VCR sensitive all ALL | 15295046 | GSE648_DOC |
| GSE649 | VCR resistant all ALL | 15295046 | GSE649_DOC |
| GSE64A | Insulin sensitive muscle sample pool 1 | 12436343 | GSE64A_DOC |
| GSE64B | Insulin sensitive muscle sample pool 1 | 12436343 | GSE64B_DOC |
| GSE64C | Insulin sensitive muscle sample pool 1 | 12436343 | GSE64C_DOC |
| GSE64D | Insulin sensitive muscle sample pool 1 | 12436343 | GSE64D_DOC |
| GSE64E | Insulin sensitive muscle sample pool 1 | 12436343 | GSE64E_DOC |
| GSE650 | DNR sensitive all ALL | 15295046 | GSE650_DOC |
| GSE651 | DNR resistant all ALL | 15295046 | GSE651_DOC |
| GSE653 | ASP sensitive B-ALL | 15295046 | GSE653_DOC |
| GSE6532A | Definition of clinically distinct molecular subtypes in estrogen receptor positive breast carcinomas using genomic grade | 17401012 | GSE6532A_DOC |
| GSE6532B | Definition of clinically distinct molecular subtypes in estrogen receptor positive breast carcinomas using genomic grade | 17401012 | GSE6532B_DOC |
| GSE6532C | Definition of clinically distinct molecular subtypes in estrogen receptor positive breast carcinomas using genomic grade | 17401012 | GSE6532C_DOC |
| GSE654 | ASP resistant B-ALL | 15295046 | GSE654_DOC |
| GSE655 | PRED sensitive B-ALL | 15295046 | GSE655_DOC |
| GSE656 | PRED resistant B-ALL | 15295046 | GSE656_DOC |
| GSE657 | VCR sensitive B-ALL | 15295046 | GSE657_DOC |
| GSE658 | VCR resistant B-ALL | 15295046 | GSE658_DOC |
| GSE659 | DNR sensitive B-ALL | 15295046 | GSE659_DOC |
| GSE65A | Insulin sensitive muscle sample pool 2 | 12436343 | GSE65A_DOC |
| GSE65B | Insulin sensitive muscle sample pool 2 | 12436343 | GSE65B_DOC |
| GSE65C | Insulin sensitive muscle sample pool 2 | 12436343 | GSE65C_DOC |
| GSE65D | Insulin sensitive muscle sample pool 2 | 12436343 | GSE65D_DOC |
| GSE65E | Insulin sensitive muscle sample pool 2 | 12436343 | GSE65E_DOC |
| GSE660 | DNR resistant B-ALL | 15295046 | GSE660_DOC |
| GSE6604A | Expression data from Normal Prostate Tissue free of any pathological alteration | 17430594 | GSE6604A_DOC |
| GSE6604B | Expression data from Normal Prostate Tissue free of any pathological alteration | 17430594 | GSE6604B_DOC |
| GSE6604C | Expression data from Normal Prostate Tissue free of any pathological alteration | 17430594 | GSE6604C_DOC |
| GSE6605A | Expression data from Metastatic Prostate Tumor | 17430594 | GSE6605A_DOC |
| GSE6605B | Expression data from Metastatic Prostate Tumor | 17430594 | GSE6605B_DOC |
| GSE6605C | Expression data from Metastatic Prostate Tumor | 17430594 | GSE6605C_DOC |
| GSE6606A | Expression data from Primary Prostate Tumor | 17430594 | GSE6606A_DOC |
| GSE6606B | Expression data from Primary Prostate Tumor | 17430594 | GSE6606B_DOC |
| GSE6606C | Expression data from Primary Prostate Tumor | 17430594 | GSE6606C_DOC |
| GSE6608A | Expression data from Normal Prostate Tissue Adjacent to Tumor | 17430594 | GSE6608A_DOC |
| GSE6608B | Expression data from Normal Prostate Tissue Adjacent to Tumor | 17430594 | GSE6608B_DOC |
| GSE6608C | Expression data from Normal Prostate Tissue Adjacent to Tumor | 17430594 | GSE6608C_DOC |
| GSE66A | Insulin sensitive muscle sample pool 3 | 12436343 | GSE66A_DOC |
| GSE66B | Insulin sensitive muscle sample pool 3 | 12436343 | GSE66B_DOC |
| GSE66C | Insulin sensitive muscle sample pool 3 | 12436343 | GSE66C_DOC |
| GSE66D | Insulin sensitive muscle sample pool 3 | 12436343 | GSE66D_DOC |
| GSE66E | Insulin sensitive muscle sample pool 3 | 12436343 | GSE66E_DOC |
| GSE675 | Time course analysis of response to HCMV infection | 11711622 | GSE675_DOC |
| GSE67A | Insulin sensitive muscle sample pool 4 | 12436343 | GSE67A_DOC |
| GSE67B | Insulin sensitive muscle sample pool 4 | 12436343 | GSE67B_DOC |
| GSE67C | Insulin sensitive muscle sample pool 4 | 12436343 | GSE67C_DOC |
| GSE67D | Insulin sensitive muscle sample pool 4 | 12436343 | GSE67D_DOC |
| GSE67E | Insulin sensitive muscle sample pool 4 | 12436343 | GSE67E_DOC |
| GSE685 | DACH1 inhibits TGF-beta signaling through binding Smad4 | 14525983 | GSE685_DOC |
| GSE68A | Insulin sensitive muscle sample pool 5 | 12436343 | GSE68A_DOC |
| GSE68B | Insulin sensitive muscle sample pool 5 | 12436343 | GSE68B_DOC |
| GSE68C | Insulin sensitive muscle sample pool 5 | 12436343 | GSE68C_DOC |
| GSE68D | Insulin sensitive muscle sample pool 5 | 12436343 | GSE68D_DOC |
| GSE68E | Insulin sensitive muscle sample pool 5 | 12436343 | GSE68E_DOC |
| GSE6919A | Expression Data from Normal and Prostate Tumor Tissues | 17430594 | GSE6919A_DOC |
| GSE6919B | Expression Data from Normal and Prostate Tumor Tissues | 17430594 | GSE6919B_DOC |
| GSE6919C | Expression Data from Normal and Prostate Tumor Tissues | 17430594 | GSE6919C_DOC |
| GSE69A | Insulin resistant muscle sample pool 1 | 12436343 | GSE69A_DOC |
| GSE69B | Insulin resistant muscle sample pool 1 | 12436343 | GSE69B_DOC |
| GSE69C | Insulin resistant muscle sample pool 1 | 12436343 | GSE69C_DOC |
| GSE69D | Insulin resistant muscle sample pool 1 | 12436343 | GSE69D_DOC |
| GSE69E | Insulin resistant muscle sample pool 1 | 12436343 | GSE69E_DOC |
| GSE701 | Transcriptional response of lymphoblastoid cells to ionizing radiation | 12915489 | GSE701_DOC |
| GSE703 | Blood pulmonary arterial hypertension | 15215156 | GSE703_DOC |
| GSE70A | Insulin resistant muscle sample pool 2 | 12436343 | GSE70A_DOC |
| GSE70B | Insulin resistant muscle sample pool 2 | 12436343 | GSE70B_DOC |
| GSE70C | Insulin resistant muscle sample pool 2 | 12436343 | GSE70C_DOC |
| GSE70D | Insulin resistant muscle sample pool 2 | 12436343 | GSE70D_DOC |
| GSE70E | Insulin resistant muscle sample pool 2 | 12436343 | GSE70E_DOC |
| GSE713 | UV radiation-induced DNA damage | 12907719 | GSE713_DOC |
| GSE71A | Insulin resistant muscle sample pool 3 | 12436343 | GSE71A_DOC |
| GSE71B | Insulin resistant muscle sample pool 3 | 12436343 | GSE71B_DOC |
| GSE71C | Insulin resistant muscle sample pool 3 | 12436343 | GSE71C_DOC |
| GSE71D | Insulin resistant muscle sample pool 3 | 12436343 | GSE71D_DOC |
| GSE71E | Insulin resistant muscle sample pool 3 | 12436343 | GSE71E_DOC |
| GSE72A | Insulin resistant muscle sample pool 4 | 12436343 | GSE72A_DOC |
| GSE72B | Insulin resistant muscle sample pool 4 | 12436343 | GSE72B_DOC |
| GSE72C | Insulin resistant muscle sample pool 4 | 12436343 | GSE72C_DOC |
| GSE72D | Insulin resistant muscle sample pool 4 | 12436343 | GSE72D_DOC |
| GSE72E | Insulin resistant muscle sample pool 4 | 12436343 | GSE72E_DOC |
| GSE7307 | Human body index - transcriptional profiling | | GSE7307_DOC |
| GSE7390 | Strong Time Dependence of the 76-Gene Prognostic Signature | 17545524 | GSE7390_DOC |
| GSE73A | Insulin resistant muscle sample pool 5 | 12436343 | GSE73A_DOC |
| GSE73B | Insulin resistant muscle sample pool 5 | 12436343 | GSE73B_DOC |
| GSE73C | Insulin resistant muscle sample pool 5 | 12436343 | GSE73C_DOC |
| GSE73D | Insulin resistant muscle sample pool 5 | 12436343 | GSE73D_DOC |
| GSE73E | Insulin resistant muscle sample pool 5 | 12436343 | GSE73E_DOC |
| GSE753 | MRI-no-lytic-lesion | 14695408 | GSE753_DOC |
| GSE754 | MRI-lytic-lesion | 14695408 | GSE754_DOC |
| GSE755 | MRI lytic and no lytic lesions | 14695408 | GSE755_DOC |
| GSE758 | Gene expression in human optic nerve head (ONH) astrocytes | 14747662 | GSE758_DOC |
| GSE764 | Comparison of Gene Expression in Uterine Smooth Muscle Tumors | | GSE764_DOC |
| GSE781A | Normal and Renal Cell Carcinoma Kidney Tissue, Human | 14641932 | GSE781A_DOC |
| GSE781B | Normal and Renal Cell Carcinoma Kidney Tissue, Human | 14641932 | GSE781B_DOC |
| GSE803A | GeneNote-Gene Normal tissue Expression | 15388519 | GSE803A_DOC |
| GSE803B | GeneNote-Gene Normal tissue Expression | 15388519 | GSE803B_DOC |
| GSE803C | GeneNote-Gene Normal tissue Expression | 15388519 | GSE803C_DOC |
| GSE803D | GeneNote-Gene Normal tissue Expression | 15388519 | GSE803D_DOC |
| GSE803E | GeneNote-Gene Normal tissue Expression | 15388519 | GSE803E_DOC |
| GSE8218 | Gene expression data from prostate cancer samples | | GSE8218_DOC |
| GSE846 | Conversion | 14702632 | GSE846_DOC |
| GSE847 | HS to HR progression | 14702632 | GSE847_DOC |
| GSE848 | E2 and SERM Treatment of MCF-7 Breast Cancer Cells | 14973112 | GSE848_DOC |
| GSE88 | Bladder tumour recurrence prediction | 12469123 | GSE88_DOC |
| GSE89 | Bladder tumour stage classification | 12469123 | GSE89_DOC |
| GSE923 | Pseudomonas aeruginosa infection of Calu-3 human lung epithelial cells | 15494517 | GSE923_DOC |
| GSE935 | NIH/NIAID Chronic Granulomatous Disease Neutrophils | 14688376 | GSE935_DOC |
| GSE96 | Large-scale analysis of the human transcriptome | 11904358 | GSE96_DOC |
| GSE973 | IL-1 stimulation of HUVEC | 15130917 | GSE973_DOC |
| GSE974 | Left ventricular apex samples | 14872006 | GSE974_DOC |
| GSE976 | Gene Expression-Based High Throughput Screening: APL Treatment with Candidate Compounds | 14770183 | GSE976_DOC |
| GSE981 | Endothelin-1 (ET-1) treated lung fibroblasts | | GSE981_DOC |
| GSE982 | Gene Expression-Based High Throughput Screening: HL-60 Cell Treatment with Candidate Compounds | 14770183 | GSE982_DOC |
| GSE983 | Gene Expression-Based High Throughput Screening: Primary Patient AML Blasts, Normal Neutrophils, and Normal Monocytes | 14770183 | GSE983_DOC |
| GSE985 | Gene Expression-Based High Throughput Screening: HL-60 Cells Treated with ATRA and PMA | 14770183 | GSE985_DOC |
| GSE995A | Differentiation of acute myeloid leukemia cells | 14770183 | GSE995A_DOC |
| GSE995B | Differentiation of acute myeloid leukemia cells | 14770183 | GSE995B_DOC |
| GSE997 | Essential Thrombocythemia megakaryocytes versus normal megakaryocytes | 15271793 | GSE997_DOC |
| GSE998 | Amino Acid Conjugated Surfaces and Controls 6 Hours | | GSE998_DOC |
| GSE999 | Amino Acid Conjugated Surfaces and Controls 32 Hours | | GSE999_DOC |
BASIC 33 | C0001 | Classification of human astrocytic gliomas | 14583454 | C0001_DOC |
| GSE1361 | Concurrent Versus Individual Binding of HuR and AUF1 to Common Labile Target mRNAs | 15257295 | GSE1361_DOC |
| GSE137 | Natural variation in human gene expression assessed in lymphoblastoid cells | 12567189 | GSE137_DOC |
| GSE1433 | TIAR represses c-Myc biosynthesis following ultraviolet light irradiation | 16537914 | GSE1433_DOC |
| GSE1434 | HaCaT +GLI1/2 24/72h | 16434164 | GSE1434_DOC |
| GSE1440 | TIAR represses c-Myc biosynthesis following ultraviolet light irradiation-2 | | GSE1440_DOC |
| GSE1510 | Human UniGene Set RZPD 1 - Zipf's Normalization | | GSE1510_DOC |
| GSE1511 | Gene expression profile of CD56dimCD16+, CD56brightCD16- and activated CD56+CD16+ human NK subsets | 15557145 | GSE1511_DOC |
| GSE1710 | Expression profiling in inflammatory bowel disease | 16107186 | GSE1710_DOC |
| GSE1748 | VI-28 treatment induced alteration of gene expression in human lymphocytes | | GSE1748_DOC |
| GSE1767 | Human blood expression for Huntington's disease versus control, Codelink | 16043692 | GSE1767_DOC |
| GSE1836 | Comparison of native versus cultured RPE cells | 16234463 | GSE1836_DOC |
| GSE2046 | Hep3B time-course | | GSE2046_DOC |
| GSE2052 | IPF versus Control | 16128620 | GSE2052_DOC |
| GSE2053 | RAvs.ND | | GSE2053_DOC |
| GSE2075 | Rosetta_miRNA_transfection_experiment | 15685193 | GSE2075_DOC |
| GSE2097 | Epigenetic treatment of cervical carcinoma cell lines | 16434596 | GSE2097_DOC |
| GSE2143 | Human coronary artery study | 15942018 | GSE2143_DOC |
| GSE2177 | Trascriptional profiling of angiogenic inhibitors | 12499246 | GSE2177_DOC |
| GSE2182 | Drug treatment comparison | | GSE2182_DOC |
| GSE2243 | RIZ1 repression is associated with insulin-like growth factor-1 signaling activation in chronic myeloid leukemia... | 16953217 | GSE2243_DOC |
| GSE2845 | Human breast tumor | | GSE2845_DOC |
| GSE3155A | Gene expression profiling of the 20 human early breast carcinomas by three miaroarray platforms | | GSE3155A_DOC |
| GSE3155B | Gene expression profiling of the 20 human early breast carcinomas by three miaroarray platforms | | GSE3155B_DOC |
| GSE3155C | Gene expression profiling of the 20 human early breast carcinomas by three miaroarray platforms | | GSE3155C_DOC |
| GSE3570 | cDNA array of the new human breast cancer cell line EM-G3 derived from breast cancer progenitor cells | | GSE3570_DOC |
| GSE4056 | Expression profiling of human primary breast cancer tissue before treatment with gemcitabine, epirubicine and docetaxel | 16622258 | GSE4056_DOC |
| GSE465F | Expression profiling in the muscular dystrophies | 11121445 | GSE465F_DOC |
| GSE4716A | Gene expression-based, individualized outcome prediction for surgically treated lung cancer patients | 15064725 | GSE4716A_DOC |
| GSE4716B | Gene expression-based, individualized outcome prediction for surgically treated lung cancer patients | 15064725 | GSE4716B_DOC |
| GSE4882 | A Gene Expression Signature to Predict Metastasis and Survival in Non-small Cell Lung Cancer | 17202451 | GSE4882_DOC |
| GSE493B | Gene expression profiling in DQA1*0501+ children with untreated dermatomyositis | 11937576 | GSE493B_DOC |
| GSE6752 | CodeLink Expression Data from primary prostate tumor and prostate tumor metastases | 17430594 | GSE6752_DOC |
COUNTS 23 | GSE10 | eye-SAGE | 11756676 | GSE10_DOC |
| GSE14 | CGAP SAGE | 11257097 | GSE14_DOC |
| GSE1439 | Differentiation of cultured THP-1 cells | | GSE1439_DOC |
| GSE17 | Young and old muscle comparison | 10904065 | GSE17_DOC |
| GSE1747 | Human 32 MPSS samples | | GSE1747_DOC |
| GSE1902 | Cancer Genome Anatomy Project (Human: longSAGE) | | GSE1902_DOC |
| GSE2017 | Genomic alterations in primary hyperaldosteronism | 16204365 | GSE2017_DOC |
| GSE2055 | Human Adrenal Cortex affected by Primary Pigmented Nodular Adrenocortical Disease | | GSE2055_DOC |
| GSE2056 | PBECs stimulated with pro-inflammatory cytokines and P. aeruginosa | 15701729 | GSE2056_DOC |
| GSE2346 | The pattern of gene expression in human CD34(+) stem/progenitor cells | 11717454 | GSE2346_DOC |
| GSE278 | Pancreas and islet gene expression | | GSE278_DOC |
| GSE31 | SAGE_HumanEpidermis | 11772949 | GSE31_DOC |
| GSE41 | Effects of estrogen | 11085516 | GSE41_DOC |
| GSE505 | Serial analysis of gene expression in the corneal endothelium of Fuchs' dystrophy | 12556388 | GSE505_DOC |
| GSE506 | Fibroblast cells immediate-early after human cytomegalovirus infection | 11124023 | GSE506_DOC |
| GSE507 | Novel estrogen and tamoxifen induced genes | 11850811 | GSE507_DOC |
| GSE508 | Targets of c-Jun NH(2)-terminal kinase 2-mediated tumor growth regulation | 12036942 | GSE508_DOC |
| GSE514 | AIDS-related Kaposi's sarcoma | 12697073 | GSE514_DOC |
| GSE545 | SAGE Hiroshima gastric cancer tissue | 15059891 | GSE545_DOC |
| GSE608 | Human embryonic stem cells | 14688391 | GSE608_DOC |
| GSE694 | SADE analysis of microdissected kidney | 14595018 | GSE694_DOC |
| GSE953 | Effect of TERT and ATM on Gene Expression Profiles in Human Fibroblasts | 14978791 | GSE953_DOC |
| HSEST | Tissue break-down of ESTs derived from Unigene clusters | 8849440 | HSEST_DOC |
CUSTOM
| GSE1133B | tissue-specific pattern of mRNA expression | 15075390 | GSE1133B_DOC |
DUAL 105 | GSE1 | NHGRI_Melanoma_class | 10952317 | GSE1_DOC |
| GSE1030A | H295RAII3h | 15375197 | GSE1030A_DOC |
| GSE1030B | H295RAII3h | 15375197 | GSE1030B_DOC |
| GSE1037 | Lung cancer | | GSE1037_DOC |
| GSE1039 | Differential Gene Expression by Memory T Helper Cells Bearing the Gut-Homing Receptor Integrin alpha
|